Shree Ram Proteins Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
Awaiting price reaction for this filing.
Shree Ram Proteins Limited reported its Q1 FY26 results, showing a loss of Rs 181.94 lakhs compared to a loss of Rs 50.21 lakhs in the same quarter last year. Total income collapsed from Rs 255.40 lakhs in Q1 FY25 to just Rs 1.37 lakhs in Q1 FY26, with effectively no revenue from operations. The auditor (HB Kalaria & Associates) issued an adverse opinion, citing multiple unresolved issues including no balance confirmations, no physical inventory or fixed asset verification, and no impairment assessment. The company acknowledged it is facing a working capital shortage, has defaulted on bank loan covenants, has unpaid statutory dues, and failed to honor installments under a One-Time Settlement (OTS) with Union Bank of India. The auditor also flagged material uncertainty about the company's ability to continue as a going concern and referenced prior CIRP (insolvency) proceedings that were settled in 2024.
This is a deeply negative filing. The combination of near-zero revenue, widening losses, an adverse auditor opinion, and explicit going-concern doubts suggests the company is in serious financial distress. Shareholders face significant risk of further value erosion, and the stock is likely to see sharp negative pressure given the insolvency history and unresolved defaults.